0001104659-24-002968.txt : 20240110 0001104659-24-002968.hdr.sgml : 20240110 20240110160520 ACCESSION NUMBER: 0001104659-24-002968 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240110 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Other Events FILED AS OF DATE: 20240110 DATE AS OF CHANGE: 20240110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 24526609 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 8-K 1 tm243059d1_8k.htm FORM 8-K
false 0001600132 0001600132 2024-01-10 2024-01-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): January 10, 2024

 

Bellerophon Therapeutics, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Delaware   001-36845   47-3116175
(State or Other Jurisdiction of Incorporation)     (Commission
File Number)
  (IRS Employer
Identification No.)

 

c/o Verdolino & Lowey, P.C.
124 Washington Street, Suite 101
Foxborough, MA
  02035

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (908) 574-4770

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class     Trading
Symbol(s)
  Name of each exchange on which
registered
Common Stock, $0.01 par value per share     BLPH   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

¨ Emerging growth company

 

¨If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

The information disclosed in Item 8.01 of this Current Report on Form 8-K is incorporated herein by reference.

 

Item 8.01 Other Events

 

On January 10, 2024, the Company convened its previously-adjourned special meeting of stockholders for the purpose of approving the Plan of Liquidation and Dissolution (the "Special Meeting"). There were 3,146,054 shares of common stock present or represented by proxy at the Special Meeting, which did not constitute a quorum under the Bylaws.

 

Accordingly, the Special Meeting was adjourned without any business being conducted in order to allow time to achieve a quorum and to allow the Company’s stockholders additional time to vote on the proposals set forth in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission (the "SEC") on November 6, 2023 (the "Proxy Statement").

 

The adjourned Special Meeting is scheduled to reconvene on Monday, January 22, 2024 at 11:00 a.m., Eastern Time, at the offices of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., 919 Third Avenue, New York, NY 10022. The close of business on October 30, 2023 will continue to be the record date for the determination of stockholders of the Company entitled to vote at the Special Meeting. Stockholders of the Company who have previously submitted their proxy or otherwise voted do not need to take any action.

 

No changes have been made in the proposals to be voted on by stockholders at the Special Meeting. The Company encourages all of its stockholders to read the Proxy Statement, which is available free of charge on the SEC website at www.sec.gov.

 

During the period of adjournment, the Company will continue to solicit votes from its stockholders with respect to the proposals set forth in the Proxy Statement. The Company encourages all stockholders who have not yet voted to do so promptly. As of October 30, 2023, the Company had 12,232,648 shares of common stock issued and outstanding.

 

Forward-Looking Statements

 

Certain statements made in this Current Report on Form 8-K are "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. The words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. Such forward-looking statements include but are not limited to statements regarding the date of the Company’s reconvened special meeting of stockholders and ability to achieve quorum. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of significant known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others that may affect actual results or outcomes, include risks and uncertainties disclosed from time to time in the Company’s filings with the SEC, including those under the heading "Risk Factors" in the Company’s latest annual report on Form 10-K filed on March 31, 2023 and in its subsequent reports. You are cautioned not to place undue reliance on forward-looking statements. All information herein speaks only as of the date hereof.

 

 

 

 

Additional Information and Where to Find It

 

In connection with the Special Meeting, the Company filed the Proxy Statement with the SEC, which was mailed to the Company’s stockholders as of the record date for the special meeting of stockholders. STOCKHOLDERS AND OTHER INTERESTED PERSONS ARE ADVISED TO READ THE DEFINITIVE PROXY STATEMENT, AS WELL AS ANY AMENDMENTS THERETO, BECAUSE IT CONTAINS IMPORTANT INFORMATION ABOUT THE MATTERS BEFORE THE STOCKHOLDERS AT THE SPECIAL MEETING. The Company’s stockholders may also obtain copies of the proxy statement and all other relevant documents filed or that will be filed with the SEC in connection with the special meeting, without charge, once available, at the SEC website at http://www.sec.gov or by directing a request to: Verdolino & Lowey, P.C. at 124 Washington St., Suite 101, Foxborough, Massachusetts 02035, Attention: Bellerophon Therapeutics.

 

Participants in the Solicitation

 

The Company and certain of its respective directors, executive officers and other members of management and employees may be deemed participants in the solicitation of proxies of the Company’s stockholders in connection with the Special Meeting. STOCKHOLDERS AND OTHER INTERESTED PERSONS MAY OBTAIN, WITHOUT CHARGE, MORE DETAILED INFORMATION REGARDING THE DIRECTORS AND OFFICERS OF THE COMPANY IN ITS ANNUAL REPORT ON FORM 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022, WHICH WAS FILED WITH THE SEC ON MARCH 31, 2023. INFORMATION REGARDING THE PERSONS WHO MAY, UNDER SEC RULES, BE DEEMED PARTICIPANTS IN THE SOLICITATION OF PROXIES TO STOCKHOLDERS IN CONNECTION WITH THE SPECIAL MEETING AND OTHER MATTERS TO BE VOTED AT THE SPECIAL MEETING ARE SET FORTH IN THE DEFINITIVE PROXY STATEMENT FOR THE SPECIAL MEETING.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BELLEROPHON THERAPEUTICS, INC.
     
Date: January 10, 2024 By: /s/ Craig Jalbert
    Name: Craig Jalbert
    Title: President

 

 

 

EX-101.SCH 2 blph-20240110.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 blph-20240110_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 4 blph-20240110_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Cover
Jan. 10, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 10, 2024
Entity File Number 001-36845
Entity Registrant Name Bellerophon Therapeutics, Inc.
Entity Central Index Key 0001600132
Entity Tax Identification Number 47-3116175
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One c/o Verdolino & Lowey, P.C.
Entity Address, Address Line Two 124 Washington Street
Entity Address, Address Line Three Suite 101
Entity Address, City or Town Foxborough
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02035
City Area Code 908
Local Phone Number 574-4770
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.01 par value per share
Trading Symbol BLPH
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 6 tm243059d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001600132 2024-01-10 2024-01-10 iso4217:USD shares iso4217:USD shares false 0001600132 8-K 2024-01-10 Bellerophon Therapeutics, Inc. DE 001-36845 47-3116175 c/o Verdolino & Lowey, P.C. 124 Washington Street Suite 101 Foxborough MA 02035 908 574-4770 false false false false Common Stock, $0.01 par value per share BLPH NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( *F *E@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " "I@"I8%87!).X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M3L,P#(9?!>7>.ND&AZC+98@32$A, G&+$F^+:-HH,6KW]J1AZX3@ 3C&_O/Y ML^36!&F&B,]Q"!C)8;J9?-NPI@:@%,#5/ M#*>I:^$*F&&$T:?O MJ%6*I_8DL'V#DY);>DQG&LQU7)Y1T$O#T]OI1U*] &W:9_+K:WN\>F&IXLZZXJ 3?-4+R6RG6[[/K#[^KL!^LV[M_ M;'P15"W\N@OU!5!+ P04 " "I@"I8F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M *F *ECMS=NEBP0 .,1 8 >&PO=V]R:W-H965T&UL MC9AO<^(V$,:_BL:]N6EG$FP9 B0'S!"2W*67Y&B@EYEV^D+8 FMB6ZXD!_CV MMS+$IE>SYD6"_^WCGU;K9V4/UE*]ZHAS0S9)G.JA$QF37;FN#B*>,-V2&4_A MS%*JA!G852M79XJSL A*8M?WO*Z;,)$ZHT%Q;*I& YF;6*1\JHC.DX2I[36/ MY7KH4.?]P+-81<8><$>#C*WXC)L_LZF"/;=4"47"4RUD2A1?#ITQO;KVNS:@ MN.*[X&M]L$WL4!92OMJ=^W#H>):(QSPP5H+!SQN?\#BV2L#Q[U[4*>]I P^W MW]7OBL'#8!9,\XF,7T1HHJ'3=TC(ERR/S;-&\,@?X\7VBB8J'_JB'8*G7H%6[U7.F,!'SI0GIJK-^Z,/OY" MN]XGA*]=\K4Q]=&-#'*H14/FVXS7P>'A_?.O"$2GA.B@*F,@" N*NYBMZBCP M^"6+-45*R)#)L:8;;D3L2< M/.7)HKZV<0W/H^?M;K]S@?#T2I[>*3S/?"5L94/.GEA2FRA99_>*8 P"U)E4A5L M9V1FX'$@4I&)S"&AD%<9ULYZ@_K-+09YX/'T%,AQ&((S0LWL-\@#7$>^I?5D MN&3@2O*=JU#""4D^LB3[1![DFF_/R+0UP2J25CV!HI:.8\_7LA8;EZ1^A[PP M'8ET9:"(X!0T3@RV:A 4MW@<-H+[U.+BHK-<0!U1CV*(5?N@N/__C#BQ>U"D M<[E.:^%PN3NY64@E\U6$T55-A>*]X&>Z\AF:*ODFTJ ^?[CFXQA#JYH*/:FK ME&A3J0V8Y%\B._Y@-_08WVNC!E0U&(IWAF(2Q[ @/XZ""UQZ?0RD:B 4]_T' M&4!.IM"AL-;;('+1ZYQW>CT/(ZIZ!\6M_D4)8W@*B4F2/-TW#EU+A0LU+9S\ MJEWXN*'/P"\#8Y%!OM0NF!B5;GT4SDL'K&?G@M3Q*,J;(&XMS3C(8K8Z80JFK'N#CICU7 M++35-]LF"UE?>[C ]_-[PLCM)HA8NN)'E\8-0D_CV>/1V;OJ$G,ER#DM7HP M9K7[HK#;,3(KWN(7TAB9%)L19_ HV O@_%)*\[YC/PR4WW5&/P!02P,$% M @ J8 J6)^@&_"Q @ X@P T !X;"]S='EL97,N>&ULW5=M:]LP$/XK M0C]@;F)JXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG:75EW8>QS:')W3VZ MNT=W)YFN6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<>Z0R5C'G55LG;6,Y M*UMP4C)9WMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6E :#7\H4)X],;NB6 M2;&W8EC+E)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,HH8T%8Q(RA._]N/P9 M,&FM5X64,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+3HOE+3T[##\^R=[8 MDMLYS8).IF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC%'S8 Y?R 5KXK;J* MW5B'_2^FO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8\>2SP:0)P:?EA6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W5_DMC)/Q]%PZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/ M[I_X3O,\3;,,J^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*P MG>*3B.T4KS4@\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0ERHY M_U=3_ 102P,$% @ J8 J6)>*NQS $P( L !?3T\ M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5* M(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'B4?'D78FYJD6:>IK&HP=MX1PT$G53$ MWHI"/J:Q8;!EK '$NW2:9;/46PQFN1BUMIS> A(H!"DHV1%[A$O\G7D(GP&LK\,S4-AB.G8RF2&]B M]#V,YU#BG/]3(U45%K"FHO409.B1P74&0ZRQB28)UD-N5G0&[O+H YMRR"9J MZJ8IGJ,.>%,.]D9/)508H'Q3F:B\]E-L.>F.7F=Z_S!YU!Y:YU;*O8=7LN48 MY0]02P,$% @ J8 J6"0>FZ*M ^ $ !H !X;"]?+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J M%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I M2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC M":[?#'!X=/X!4$L#!!0 ( *F *EAED'F2&0$ ,\# 3 6T-O;G1E M;G1?5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=: MTMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E) M_)JV(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I* M&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7H MK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC* M30H1.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^D&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( M *F *ECMS=NEBP0 .,1 8 " @0T( !X;"]W;W)K&PO&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 M " "I@"I899!YDAD! #/ P $P @ '8$@ 6T-O;G1E C;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" B% ! end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 1 24 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://bellerophon.com/role/Cover Cover Cover 1 false false All Reports Book All Reports blph-20240110.xsd blph-20240110_lab.xml blph-20240110_pre.xml tm243059d1_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm243059d1_8k.htm": { "nsprefix": "BLPH", "nsuri": "http://bellerophon.com/20240110", "dts": { "schema": { "local": [ "blph-20240110.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "blph-20240110_lab.xml" ] }, "presentationLink": { "local": [ "blph-20240110_pre.xml" ] }, "inline": { "local": [ "tm243059d1_8k.htm" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://bellerophon.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-01-10", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm243059d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-01-10", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm243059d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://bellerophon.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 13 0001104659-24-002968-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-002968-xbrl.zip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